Ellume’s New Tuberculosis Test Approved for Use in Low-Resource Countries
Tech to advance the control of tuberculosis in areas with limited infrastructure has been approved by the Global Fund’s Expert Review Panel for Diagnostics.
Read MorePosted by Andy Lundin | Jan 13, 2022 | Respiratory Disease |
Tech to advance the control of tuberculosis in areas with limited infrastructure has been approved by the Global Fund’s Expert Review Panel for Diagnostics.
Read MorePosted by Andy Lundin | Jan 12, 2022 | Immunoassay Reagents & test Kits |
Private health insurers will soon be required to cover COVID-19 tests for those they are covering, the Biden administration announced.
Read MorePosted by Andy Lundin | Jan 12, 2022 | Molecular Diagnostics |
BD, Pfizer, and global charitable foundation Wellcome are collaborating to highlight how diagnostic best practices can improve patient care.
Read MorePosted by Andy Lundin | Jan 11, 2022 | Lab Automation |
The FDA has granted Rheonix 510(k) clearance of its automated Encompass MDxWorkstation, along with its STI TriPlex Assay and male STI detection kit.
Read MorePosted by Andy Lundin | Jan 11, 2022 | Covid 19 |
Researchers from Seattle published insights toward reforming actions made during the pandemic that hampered community testing of COVID-19 in the city.
Read More